Get the Stockscreener App
18.28
0.05%
0.01
Pre-market:
18.15
-0.13
-0.71%
Innoviva Inc stock is traded at $18.28, with a volume of 748.23K.
It is up +0.05% in the last 24 hours and up +5.85% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$18.27
Open:
$18.17
24h Volume:
748.23K
Relative Volume:
0.93
Market Cap:
$1.13B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
11.08
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
+1.67%
1M Performance:
+5.85%
6M Performance:
-7.91%
1Y Performance:
+22.27%
1-Day Range:
$18.07
$18.37
1-Week Range:
$17.92
$18.37
52-Week Range:
$14.83
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.28 | 1.13B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Insider Selling Buzz: Innoviva Inc [INVA] 10% Owner DENNER ALEXANDER J sold 1,196,746 shares of the company - knoxdaily.com
(INVA) Trading Report - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating - Defense World
Russell Investments Group Ltd. Decreases Stake in Innoviva, Inc. (NASDAQ:INVA) - The AM Reporter
Are Innoviva, Inc.'s (NASDAQ:INVA) Mixed Financials Driving The Negative Sentiment? - Yahoo Finance
Vanguard Group Inc. Buys 84,934 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Corebridge Financial Inc. Sells 2,299 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva NASDAQ: INVA $18.07 0 (0.00%) Apr 2, 2025 4 - MarketScreener
Thrivent Financial for Lutherans Has $739,000 Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Teacher Retirement System of Texas Grows Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - Defense World
Where are the Opportunities in (INVA) - news.stocktradersdaily.com
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Raised by HighTower Advisors LLC - Defense World
Can Mixed Fundamentals Have A Negative Impact on Innoviva, Inc. (NASDAQ:INVA) Current Share Price Momentum? - Simply Wall St
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - MSN
Avantax Advisory Services Inc. Grows Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Upgraded to “Buy” at StockNews.com - Defense World
Charles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Sarissa Capital Management LP Reduces Stake in Innoviva Inc. - GuruFocus.com
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by PNC Financial Services Group Inc. - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc. - Defense World
Innoviva (NASDAQ:INVA) Downgraded by StockNews.com to Hold - Defense World
Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - Longview News-Journal
(INVA) Investment Analysis and Advice - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Research Coverage Started at Scotiabank - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in Stock - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $20,966,989.92 in Stock - Defense World
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - Nasdaq
Innoviva stock sees $28 million sale by Alexander J. Denner - Investing.com Australia
Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - BioSpace
Innoviva CEO Fireside Chat: What Strategic Updates Await at Barclays Healthcare Conference? - Stock Titan
Principal Financial Group Inc. Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Has $3.25 Million Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lowered by Denali Advisors LLC - MarketBeat
When the Price of (INVA) Talks, People Listen - news.stocktradersdaily.com
Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results - MarketBeat
Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat
Innoviva (INVA) to Release Earnings on Thursday - Defense World
Innoviva: Q4 Earnings Snapshot - Thehour.com
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - marketscreener.com
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
4.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):